Citation Impact
Citing Papers
Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy
2010
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
2017
The gut microbiota and host health: a new clinical frontier
2015 Standout
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Nucleotide Oligomerization Binding Domain-Like Receptor Signaling Enhances Dendritic Cell-Mediated Cross-Priming In Vivo
2009 StandoutNobel
Potent Tumor-Specific Protection Ignited by Adoptively Transferred CD4+ T Cells
2008
Constitutive Expression of IDO by Dendritic Cells of Mesenteric Lymph Nodes: Functional Involvement of the CTLA-4/B7 and CCL22/CCR4 Interactions
2009 StandoutNobel
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
2010 Standout
Therapeutic Immunity by Adoptive Tumor-primed CD4+ T-cell Transfer in Combination With In Vivo GITR Ligation
2009 StandoutNobel
Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation
2015 StandoutNobel
TMEM173 variants and potential importance to human biology and disease
2018
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohnʼs Disease, and Pouchitis
2013
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
2019
Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model
2008
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Gene Modification Strategies to Induce Tumor Immunity
2005
On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape
2021 StandoutNobel
Lipid nanoparticles for mRNA delivery
2021 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?
2018 StandoutNobel
Macrophages in immunoregulation and therapeutics
2023 Standout
Dendritic Cells and Cancer Immunity
2016
STING: infection, inflammation and cancer
2015
Type I interferons in infectious disease
2015 Standout
The biology and function of fibroblasts in cancer
2016 Standout
miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity
2017
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Microbiota-Driven Tonic Interferon Signals in Lung Stromal Cells Protect from Influenza Virus Infection
2019
The molecular machinery of regulated cell death
2019 Standout
Therapeutic effect of α‐galactosylceramide‐loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells
2005
An ionizable lipid toolbox for RNA delivery
2021 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Using Recombinant Lactococci as an Approach to Dissect the Immunomodulating Capacity of Surface Piliation in Probiotic Lactobacillus rhamnosus GG
2013
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Dental caries
2017 Standout
Programming CAR-T cells to kill cancer
2018
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
2015
Anti-TGEV Miller Strain Infection Effect of Lactobacillus plantarum Supernatant Based on the JAK-STAT1 Signaling Pathway
2019
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Tumor-Associated Macrophages as Target for Antitumor Therapy
2017
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment
2017
Potential Role of Gut Microbiota in Induction and Regulation of Innate Immune Memory
2019
Th17 Cells in Cancer: The Ultimate Identity Crisis
2014
Gut microbiota and Covid-19- possible link and implications
2020 Standout
Influence of diet on the gut microbiome and implications for human health
2017 Standout
Immunomodulatory functional foods and their molecular mechanisms
2022
Advances in plant molecular farming
2010
Regulation of type I interferon responses
2013 Standout
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
The STING pathway and the T cell-inflamed tumor microenvironment
2015
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Microbiota Modulation of the Gut-Lung Axis in COVID-19
2021 Standout
An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen
2006
A Chimeric HIV-1 Envelope Glycoprotein Trimer with an Embedded Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Domain Induces Enhanced Antibody and T Cell Responses
2011
Function of the intestinal epithelium and its dysregulation in inflammatory bowel disease
2010
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
2019
Molecular and cellular insights into T cell exhaustion
2015 Standout
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
Interferons α and β in cancer: therapeutic opportunities from new insights
2019
Innate immune signaling and regulation in cancer immunotherapy
2016
Driving gene-engineered T cell immunotherapy of cancer
2016
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
2019
HPLC Purification of In Vitro Transcribed Long RNA
2012 StandoutNobel
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
2018
The pros, cons, and many unknowns of probiotics
2019 Standout
Interleukin-28B dampens airway inflammation through up-regulation of natural killer cell-derived IFN-γ
2017
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
2018 StandoutNobel
Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist
2014 StandoutNobel
Consumption of Dairy Yogurt Containing Lactobacillus paracasei ssp. paracasei, Bifidobacterium animalis ssp. lactis and Heat-Treated Lactobacillus plantarum Improves Immune Function Including Natural Killer Cell Activity
2017
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
2020
An Essential Role of Antigen-Presenting Cell/T-Helper Type 1 Cell-Cell Interactions in Draining Lymph Node during Complete Eradication of Class II–Negative Tumor Tissue by T-Helper Type 1 Cell Therapy
2006
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer
2015
Oral administration of carbonic anhydrase I ameliorates murine experimental colitis induced by Foxp3−CD4+CD25− T cells
2013
Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy
2020
Current Patent and Clinical Status of Stimulator of Interferon Genes (STING) Agonists for Cancer Immunotherapy
2019
Modulation of host responses by oral commensal bacteria
2015
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
2018 StandoutScience
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
The host STING pathway at the interface of cancer and immunity
2016
Glycosylation Changes in Brain Cancer
2017
Characterization of Dendritic Cells and Macrophages Generated by Directed Differentiation from Mouse Induced Pluripotent Stem Cells
2009 StandoutNobel
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design
2011 StandoutNobel
Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
2017
Works of Akemi Kosaka being referenced
STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
2014
Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses
2011
Oral tolerance: intestinal homeostasis and antigen-specific regulatory T cells
2008
Expression of miR-17-92 enhances anti-tumor activity of T-cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts
2013
NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by α-galactosylceramide in vivo
2004
Lactococcus lactis subsp. cremoris FC triggers IFN-γ production from NK and T cells via IL-12 and IL-18
2012
An efficient method to prepare T cell receptor gene‐transduced cytotoxic T lymphocytes type 1 applicable to tumor gene cell‐therapy
2003
Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells
2014
Extraction and purification of human interleukin-10 from transgenic rice seeds
2010
Protective role of STING against gliomagenesis: Rational use of STING agonist in anti-glioma immunotherapy
2015
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site
2017
Critical role of the Th1/Tc1 circuit for the generation of tumor‐specific CTL during tumor eradication in vivo by Th1‐cell therapy
2003
Double-Stranded RNA of Intestinal Commensal but Not Pathogenic Bacteria Triggers Production of Protective Interferon-β
2013
Abstract 2804: Expression of miR-17-92 enhances antitumor activity of T cells transduced with the anti-EGFRvIII chimeric antigen receptor in mice bearing human GBM xenografts
2014
Potentiation of Tumor Eradication by Adoptive Immunotherapy with T-cell Receptor Gene-Transduced T-Helper Type 1 Cells
2004
Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
2017
Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity
2015